Immix Biopharma, INC. 8-K Filing
Ticker: IMMX · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1873835
Sentiment: neutral
Filing Stats: 1,283 words · 5 min read · ~4 pages · Grade level 12 · Accepted 2025-12-08 06:15:37
Key Financial Figures
- $0.0001 — registered Common Stock, par value of $0.0001 per share IMMX The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 22KB
- 0001493152-25-026500.txt ( ) — 237KB
- immx-20251207.xsd (EX-101.SCH) — 3KB
- immx-20251207_lab.xml (EX-101.LAB) — 33KB
- immx-20251207_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Immix Biopharma, Inc. Dated: December 8, 2025 /s/ Ilya Rachman Ilya Rachman, Ph.D., M.D. Chief Executive Officer